These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 1653713
1. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension]. Mori K. Nihon Naibunpi Gakkai Zasshi; 1991 Jul 20; 67(7):796-810. PubMed ID: 1653713 [Abstract] [Full Text] [Related]
2. [The significance of cGMP and dopamine receptor on the natriuretic and hypotensive activities of synthetic atrial natriuretic polypeptide in essential hypertension]. Mori K, Shigetomi S, Kohno H, Tosaki H, Kato K, Tanaka K, Haga H, Kin S, Fukuchi S. Nihon Naibunpi Gakkai Zasshi; 1990 Feb 20; 66(2):83-93. PubMed ID: 2158911 [Abstract] [Full Text] [Related]
4. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man. Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Livesey JH. J Clin Endocrinol Metab; 1987 Oct 20; 65(4):765-72. PubMed ID: 2821056 [Abstract] [Full Text] [Related]
5. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient]. Iannettone CM, Strazzulla G, Fabbri G, Piazza E, Valenza T, De Feo ML, Franchi F. Ann Ital Med Int; 1991 Oct 20; 6(3):273-83. PubMed ID: 1837999 [Abstract] [Full Text] [Related]
7. Cardiovascular, renal and endocrine effects of alpha-human atrial natriuretic peptide in patients with Cushing's syndrome and primary aldosteronism. Fujio N, Ohashi M, Nawata H, Kato K, Matsuo H, Ibayashi H. J Hypertens; 1989 Aug 20; 7(8):653-9. PubMed ID: 2553806 [Abstract] [Full Text] [Related]
8. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition. Wambach G, Schittenhelm U, Bönner G, Kaufmann W. Cardiology; 1989 Aug 20; 76(6):418-27. PubMed ID: 2558792 [Abstract] [Full Text] [Related]
9. Renal effects of atrial natriuretic peptide during dopamine infusion. Hirata Y, Fukui K, Hayakawa H, Suzuki E, Sugimoto T, Kimura K, Matsuoka H, Sugimoto T. Am J Hypertens; 1990 Nov 20; 3(11):866-9. PubMed ID: 2175625 [Abstract] [Full Text] [Related]
10. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake. Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Joyce SL, Gilchrist NL. J Clin Endocrinol Metab; 1986 Oct 20; 63(4):946-53. PubMed ID: 2943757 [Abstract] [Full Text] [Related]
17. Treatment of intraoperative hypertension with enflurane, nicardipine, or human atrial natriuretic peptide: haemodynamic and renal effects. Goto F, Kato S, Sudo I. Can J Anaesth; 1992 Nov 20; 39(9):932-7. PubMed ID: 1451221 [Abstract] [Full Text] [Related]
19. Effect of low dose infusion of atrial natriuretic peptide on renal function in man. Solomon LR, Atherton JC, Bobinski H, Hillier V, Green R. Clin Sci (Lond); 1988 Oct 20; 75(4):403-10. PubMed ID: 2973849 [Abstract] [Full Text] [Related]
20. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats. Wegner M, Ganten D, Stasch JP. Hypertens Res; 1996 Dec 20; 19(4):229-38. PubMed ID: 8986453 [Abstract] [Full Text] [Related] Page: [Next] [New Search]